Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP715733.RAJ2V_Js6YAY-lTZjKkasEZZlfRzAmWyCg_HgzlkLjKBQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP715733.RAJ2V_Js6YAY-lTZjKkasEZZlfRzAmWyCg_HgzlkLjKBQ130_assertion type Assertion NP715733.RAJ2V_Js6YAY-lTZjKkasEZZlfRzAmWyCg_HgzlkLjKBQ130_head.
- NP715733.RAJ2V_Js6YAY-lTZjKkasEZZlfRzAmWyCg_HgzlkLjKBQ130_assertion description "[In particular, these include significantly reduced expression levels of three matrix metallopeptidases (MMP1, MMP3, MMP16), follistatin, and STAT1, and significantly increased expression levels of fibroblast growth factors (FGF9, FGF11), a number of collagen genes and other ECM genes in DD patient samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715733.RAJ2V_Js6YAY-lTZjKkasEZZlfRzAmWyCg_HgzlkLjKBQ130_provenance.
- NP715733.RAJ2V_Js6YAY-lTZjKkasEZZlfRzAmWyCg_HgzlkLjKBQ130_assertion evidence source_evidence_literature NP715733.RAJ2V_Js6YAY-lTZjKkasEZZlfRzAmWyCg_HgzlkLjKBQ130_provenance.
- NP715733.RAJ2V_Js6YAY-lTZjKkasEZZlfRzAmWyCg_HgzlkLjKBQ130_assertion SIO_000772 23554969 NP715733.RAJ2V_Js6YAY-lTZjKkasEZZlfRzAmWyCg_HgzlkLjKBQ130_provenance.
- NP715733.RAJ2V_Js6YAY-lTZjKkasEZZlfRzAmWyCg_HgzlkLjKBQ130_assertion wasDerivedFrom befree-20150227 NP715733.RAJ2V_Js6YAY-lTZjKkasEZZlfRzAmWyCg_HgzlkLjKBQ130_provenance.
- NP715733.RAJ2V_Js6YAY-lTZjKkasEZZlfRzAmWyCg_HgzlkLjKBQ130_assertion wasGeneratedBy ECO_0000203 NP715733.RAJ2V_Js6YAY-lTZjKkasEZZlfRzAmWyCg_HgzlkLjKBQ130_provenance.